Teams from Fudan University, CEIBS, the University of California Irvine, HEC, Mannheim Business School, and IESE were selected from dozens of competitors to participate in today’s final, where they pitched business ideas related to globalising Chinese healthcare innovations to an esteemed jury.

Today’s panel of judges included: Vivian Ding, VP (Strategy and Development) at Boehringer Ingelheim China; Nisa Leung, Managing Partner at Qiming Venture Partners; Dr. Thomas Herget, Head of Group Innovation Technology Fields at the Merck Group Science and Technology Office; Jin Wang, Co-Leader of the China Healthcare Practice at McKinsey & Co.; Gil Bashe, Managing Partner of Global Health at FINN Partners; and Eric Bouteiller, Adjunct Professor of Management at CEIBS.

The six finalist teams and their business ideas are:

During the opening ceremony, CEIBS Associate Dean and MBA Director Shameen Prashantham shared, “As the leading MBA programme in Asia, CEIBS is committed to educating responsible leaders versed in ‘China Depth’ and ‘Global Breadth’. The INNOVATEChina competition offers a platform for aspiring global leaders to learn more about the Chinese market, to interact with their peers from top business schools globally, and to test their business acumen and pitch in front of a panel of experienced industry and academic experts.”

CEIBS MBA Administration Director Michelle Zhu, who revealed the winners, shared, “Having witnessed many INNOVATEChina competitions in the past, I believe that this event is an important reflection of CEIBS’ exceptional positioning as a business school that bridges China with the world. While COVID-19 restrictions have been a challenging problem for all Shanghai-based events, I am proud that this year the organizing team managed to deliver the tenth edition of INNOVATEChina in this online format, and would like to congratulate the team on their hard work.”

On behalf of the organising team, INNOVATEChina 2022 President Karen Xi said, “Although we could only provide three cash prizes, we hope that all teams received valuable feedback on their business plans from our esteemed jury and enjoyed the opportunity to interact with fellow business school students from around the world.”

INNOVATEChina 2022 Vice President Edward Tang stated, “INNOVATEChina 2022 marks the tenth anniversary of this flagship CEIBS MBA competition, and we are honoured to have been given the opportunity to continue this important tradition, to showcase the vibrancy of the Chinese healthcare innovation ecosystem, and also to provide an important platform for international exchange between Chinese and global business schools.”

“We would also like to acknowledge the tremendous contributions of our partners, without whom this competition would not have been possible: Boehringer Ingelheim, Qiming Venture Partners and Merck Group as industry partners; McKinsey & Company as our knowledge partner; and the Galien Foundation as a global partner,” he added.

About INNOVATEChina

First launched in 2008, INNOVATEChina is one of the largest global business innovation competitions. Every year, dozens of teams from the world’s leading business schools and educational institutions compete to win this prestigious competition. INNOVATEChina provides an intellectually stimulating platform for entrepreneurial and dynamic individuals to validate their most innovative business ideas and receive invaluable mentoring from top faculty members and industry leaders. For more information, please visit https://innovatechina.net or scan to follow us on WeChat.

The 2022 Core Organising Team includes six CEIBS MBA 2023 students: Karen Xi as President; Edward Tang as Vice President; along with Adam Jin, David Cheng, Fred Hu and Rita Qiu as core members. CEIBS Associate Professor of Entrepreneurship Terry Taiyuan Wang and CEIBS Adjunct Professor of Management, Eric Bouteiller serve as faculty advisors, with Daniel Wang, Head of the CEIBS eLab, serving as the MBA Office representative. To contact the Organising Team of INNOVATEChina2022, please click here.

About China Europe International Business School (CEIBS)

China Europe International Business School (CEIBS) was co-founded by the Chinese government and European Union (EU) in 1994. CEIBS is committed to educating responsible leaders versed in ‘China Depth, Global Breadth’ in line with its motto of ‘Conscientiousness, Innovation and Excellence.’ The 16-month CEIBS MBA programme was ranked #16 in the world and #1 in Asia by the Financial Times in 2022. CEIBS has campuses in Shanghai, Beijing and Shenzhen in China; Accra in Ghana; and Zurich in Switzerland. For more information, please visit click here.